Vanguard Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vanguard Capital Management's LLY Position: Q3 2026 in Review
Vanguard Capital Management increased its Eli Lilly (LLY) stake by 0.73% in Q3 2026, buying an estimated $463M and bringing the position to 53,921,209 shares worth $62.4B. The position accounts for 1.31% of the portfolio, ranked #12.
Vanguard Capital Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $64.2B in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Vanguard Capital Management held 53,921,209 shares of Eli Lilly worth $62.4B as of Q3 2026.
- Vanguard Capital Management bought 392,341 Eli Lilly shares in Q3 2026, an estimated $463M.
- Eli Lilly made up 1.31% of Vanguard Capital Management's portfolio in Q3 2026, its #12 holding.
- Vanguard Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Eli Lilly position peaked at $64.2B in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.